What's new in the extracorporeal treatment of sepsis?
Department of Intensive Care Medicine (710), Radboud University Medical Centre, Geert Grooteplein Zuid 10, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands. peter.pickkers@radboudumc.nl.
Peter
http://orcid.org/0000-0002-1104-4303
P
Pickkers
Department of Anesthesiology and Intensive Care, Hôpital Lariboisière APHP, Université Paris 7 Denis Diderot, UMR INSERM 1160, 2 Rue Ambroise Paré, 76010, Paris, France.
Didier
D
Payen
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016638:Critical Illness / Q000628:therapy; D019446:Endotoxemia / Q000628:therapy; D004731:Endotoxins / Q000009:adverse effects; D006464:Hemoperfusion / Q000379:methods*; D006801:Humans; D015994:Incidence; D011112:Polymyxin B / Q000627:therapeutic use; D012772:Shock, Septic / Q000401:mortality / Q000628:therapy*
D000900:Anti-Bacterial Agents; D004731:Endotoxins; D011112:Polymyxin B